Recurrent oncogenic JAK and STAT alterations in cutaneous CD30-positive lymphoproliferative disorders. Maurus K, Appenzeller S, Roth S, Brandlein S, et al. J Invest Dermatol 2020 Mar 5. pii: S0022-202X(20)30239.

Read + Share

Amedeo Smart

Independent Medical Education

Maurus K, Appenzeller S, Roth S, Brandlein S, et al. Recurrent oncogenic JAK and STAT alterations in cutaneous CD30-positive lymphoproliferative disorders. J Invest Dermatol 2020 Mar 5. pii: S0022-202X(20)30239.
PMID: 32147503